Sequenom Preliminary 2013 Revenue Rise Approx. 81% Year-over-year

(RTTNews) - Sequenom Inc. (SQNM) reported Preliminary 2013 total revenue of approximately $162 million, an increase of approximately 81% year-over-year. Primarily diagnostic services revenues were approximately $120 million, compared to $46.5 million in 2012.

The company said it has established primary financial and R&D objectives for 2014 to include: achieve quarterly break-even and positive cash flow in the fourth quarter of 2014; expand the NIPT, or noninvasive prenatal testing, menu with the development of a low cost test on an alternative platform by year-end. The company expects its alternative platform will facilitate international access and potential future entry into the low-risk market.